Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Sales $ 1,817,302 $ 1,526,075
Cost of sales (1,946,900) (1,760,451)
Gross loss (129,598) (234,376)
Operating Expenses    
Selling and marketing 347,808 154,626
General and administrative 7,014,919 6,107,016
Depreciation and amortization 193,065 64,853
Total operating expenses 7,555,792 6,326,495
Loss from Operations (7,685,390) (6,560,871)
Other Expenses    
Interest expense, net 320,571 207,913
Gain on sale of investment in subsidiary (199,200)
Common stock price modification 941,530
Warrant modification expenses 89,549
Total other expenses 121,371 1,238,992
Loss from Continuing Operations (7,806,761) (7,799,863)
Loss from Discontinued Operations (105,751) (2,242,278)
Net Loss (7,912,512) (10,042,141)
Dividends to preferred stockholders (345,079)
Net Loss Attributable to Common Stockholders $ (8,257,591) $ (10,042,141)
Net loss per basic and diluted common share:    
Loss from continuing operations $ (0.19) $ (0.19)
Loss from discontinued operations (0.06)
Net loss per common share $ (0.19) $ (0.24)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 42,996,124 41,078,655